BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 22017584)

  • 1. Molecular mechanisms of fragile X syndrome: a twenty-year perspective.
    Santoro MR; Bray SM; Warren ST
    Annu Rev Pathol; 2012; 7():219-45. PubMed ID: 22017584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice.
    Iliff AJ; Renoux AJ; Krans A; Usdin K; Sutton MA; Todd PK
    Hum Mol Genet; 2013 Mar; 22(6):1180-92. PubMed ID: 23250915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNAs and Fragile X Syndrome.
    Lin SL
    Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.
    Bassell GJ; Warren ST
    Neuron; 2008 Oct; 60(2):201-14. PubMed ID: 18957214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
    Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
    PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The state of synapses in fragile X syndrome.
    Pfeiffer BE; Huber KM
    Neuroscientist; 2009 Oct; 15(5):549-67. PubMed ID: 19325170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse.
    Ronesi JA; Huber KM
    Sci Signal; 2008 Feb; 1(5):pe6. PubMed ID: 18272470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors.
    Nakamoto M; Nalavadi V; Epstein MP; Narayanan U; Bassell GJ; Warren ST
    Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15537-42. PubMed ID: 17881561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragile X syndrome: From protein function to therapy.
    Bagni C; Oostra BA
    Am J Med Genet A; 2013 Nov; 161A(11):2809-21. PubMed ID: 24115651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CGG-repeat dynamics and
    Zhou Y; Kumari D; Sciascia N; Usdin K
    Mol Autism; 2016; 7():42. PubMed ID: 27713816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures.
    Myrick LK; Deng PY; Hashimoto H; Oh YM; Cho Y; Poidevin MJ; Suhl JA; Visootsak J; Cavalli V; Jin P; Cheng X; Warren ST; Klyachko VA
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):949-56. PubMed ID: 25561520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome.
    Muddashetty RS; Kelić S; Gross C; Xu M; Bassell GJ
    J Neurosci; 2007 May; 27(20):5338-48. PubMed ID: 17507556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
    Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
    Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome.
    Gross C; Nakamoto M; Yao X; Chan CB; Yim SY; Ye K; Warren ST; Bassell GJ
    J Neurosci; 2010 Aug; 30(32):10624-38. PubMed ID: 20702695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses.
    Antar LN; Afroz R; Dictenberg JB; Carroll RC; Bassell GJ
    J Neurosci; 2004 Mar; 24(11):2648-55. PubMed ID: 15028757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.
    Nosyreva ED; Huber KM
    J Neurophysiol; 2006 May; 95(5):3291-5. PubMed ID: 16452252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The feasibility and utility of hair follicle sampling to measure FMRP and FMR1 mRNA in children with or without fragile X syndrome: a pilot study.
    Jalnapurkar I; Frazier JA; Roth M; Cochran DM; Foley A; Merk T; Venuti L; Ronco L; Raines S; Cadavid D
    J Neurodev Disord; 2022 Dec; 14(1):57. PubMed ID: 36494616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.
    De Rubeis S; Fernández E; Buzzi A; Di Marino D; Bagni C
    Adv Exp Med Biol; 2012; 970():517-51. PubMed ID: 22351071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragile X syndrome: mechanistic insights and therapeutic avenues regarding the role of potassium channels.
    Lee HY; Jan LY
    Curr Opin Neurobiol; 2012 Oct; 22(5):887-94. PubMed ID: 22483378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The translation of translational control by FMRP: therapeutic targets for FXS.
    Darnell JC; Klann E
    Nat Neurosci; 2013 Nov; 16(11):1530-6. PubMed ID: 23584741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.